TLR9-targeted biodegradable nanoparticles as immunization vectors protect against West Nile encephalitis. - Test2 - elhamkhani - TriplyDB

TLR9-targeted biodegradable nanoparticles as immunization vectors protect against West Nile encephalitis.

TLR9-targeted biodegradable nanoparticles as immunization vectors protect against West Nile encephalitis.

http://www.wikidata.org/entity/Q37120117

about

Recent progress in West Nile virus diagnosis and vaccination West Nile Virus: biology, transmission, and human infection Particle-mediated delivery of cytokines for immunotherapy Vaccines in development against West Nile virus Structure-dependent immunostimulatory effect of CpG oligodeoxynucleotides and their delivery system Delivery of host cell-directed therapeutics for intracellular pathogen clearance Particulate delivery systems for vaccination against bioterrorism agents and emerging infectious pathogens A Novel Synthetic TLR-4 Agonist Adjuvant Increases the Protective Response to a Clinical-Stage West Nile Virus Vaccine Antigen in Multiple Formulations Functionalized iron oxide nanoparticles for controlling the movement of immune cells Biodegradable Polymeric Nanoparticles-Based Vaccine Adjuvants for Lymph Nodes Targeting Plant-made vaccines against West Nile virus are potent, safe, and economically feasible Synthetic Nanoparticles for Vaccines and Immunotherapy Combinatorial Delivery of Dual and Triple TLR Agonists via Polymeric Pathogen-like Particles Synergistically Enhances Innate and Adaptive Immune Responses.Antigen-displaying lipid-enveloped PLGA nanoparticles as delivery agents for a Plasmodium vivax malaria vaccine The nanomaterial-dependent modulation of dendritic cells and its potential influence on therapeutic immunosuppression in lupus.Poly(lactic acid) and poly(lactic-co-glycolic acid) particles as versatile carrier platforms for vaccine delivery.Analysis of the murine immune response to pulmonary delivery of precisely fabricated nano- and microscale particles.Nanomedicine in GI Current trends in West Nile virus vaccine development.Enhancing humoral responses to a malaria antigen with nanoparticle vaccines that expand Tfh cells and promote germinal center induction.The impact of nanoparticle ligand density on dendritic-cell targeted vaccines.Beyond antigens and adjuvants: formulating future vaccines.Biomaterial Strategies for Immunomodulation.Configuration-dependent Presentation of Multivalent IL-15:IL-15Rα Enhances the Antigen-specific T Cell Response and Anti-tumor Immunity Kinetics of the West Nile virus induced transcripts of selected cytokines and Toll-like receptors in equine peripheral blood mononuclear cells Risk factors for West Nile virus infection and disease in populations and individuals.Engineering nano- and microparticles to tune immunity A plant-produced antigen elicits potent immune responses against West Nile virus in mice.West Nile virus: the complex biology of an emerging pathogen.Bio-inspired, bioengineered and biomimetic drug delivery carriers.Immunization of Zika virus envelope protein domain III induces specific and neutralizing immune responses against Zika virus.Small Wonders-The Use of Nanoparticles for Delivering Antigen.Engineered Materials for Cancer Immunotherapy.An Overview of Current Approaches Toward the Treatment and Prevention of West Nile Virus Infection.Immunomodulatory nanoparticles ameliorate disease in the Leishmania (Viannia) panamensis mouse model.Artificial bacterial biomimetic nanoparticles synergize pathogen-associated molecular patterns for vaccine efficacy.Synthetic nanovaccines for immunotherapy.Adsorption of a porcine reproductive and respiratory syndrome virus DNA vaccine candidate onto biodegradable nanoparticles improves immunogenicity in mice.Co-delivery of Dual Toll-Like Receptor Agonists and Antigen in Poly(Lactic-Co-Glycolic) Acid/Polyethylenimine Cationic Hybrid Nanoparticles Promote Efficient In Vivo Immune Responses.Reduced severity of peanut-induced anaphylaxis in TLR9-deficient mice is associated with selective defects in humoral immunity.

P2860

Q21284433-248E1C94-A3E8-4159-9348-F5D62D293D4A Q26865618-391070FF-87EF-4FE1-983A-FBCC952B09BF Q26997993-0653E4AC-3AFC-4385-88C5-6494AC9BD716 Q26999702-CE3286D4-6A26-4356-B626-217F553763A5 Q27004381-D724D23A-63CE-4E03-82F0-13F5BF39E6F7 Q27006858-26D93B3E-E7C9-4F52-B7E9-5AD14D5952B6 Q27011190-59AD6A0E-E0A4-48E5-A1E5-5B317ABEC274 Q27321020-A7DC1B8B-225F-4FEC-89F6-E002F2385DE5 Q27336194-368D5131-2CDB-4255-ABD3-05D1BB31190A Q28072997-F1D78D62-8C6C-49CF-955D-D20A19CE37CA Q28082778-34C6202F-9CA0-4859-A763-9FC08BF1BFE5 Q28085375-3C0BC3CD-DD53-4A9C-B7EB-DDE6625E4195 Q33746872-13475A58-C4D6-48D2-95DC-A79A54C747AD Q34157315-4CA3114A-6D33-41D6-BD43-546C6833577A Q34180779-AC454A4F-DADF-473D-BCAE-93BE34C6F32F Q34455041-AD1A5BB0-CF94-4F6A-B098-54CE4AFAD4E3 Q34675068-F2D1E07B-9C54-46BB-B608-61CF771FBC2C Q34719056-74F6234F-5419-4494-936E-DD24E54EDA58 Q34788758-B7C18E71-12CA-420E-AE1D-81FBA5BABA4A Q35709003-8A0F9BDA-F129-4014-A7C7-EF246E4E182F Q36062758-2F7FBF32-DB36-4AEC-AF90-011A648476D1 Q36618500-DE30BC1C-0AC0-43EA-ABFF-9D61063E6F07 Q36703124-EBE12238-0D1E-41FA-B4F9-E658FC29D06C Q36884768-D8D586F4-A7C7-4273-99E1-426E80D46BF1 Q36976064-B832821B-6BD4-40FF-A1CA-0336F53C94C1 Q37082586-59ECB258-F867-4471-A5E8-5CE11A016C53 Q37205125-EDEF7CDD-2BE0-4E11-9D90-1AD738065B5B Q37717816-32B0C812-9D28-4CF9-980D-ED8E4A1E7B0C Q37876095-9F9FCD85-CBD4-4E4A-9AD0-A7F96BA7AE21 Q37896455-4534BF97-AC24-4B97-8651-AE24D31E504A Q38158247-C755EFD0-D6FE-48FF-86D2-1F68B5B9992F Q38583148-4D89D996-0DC1-406E-B5C2-54AF15E63ADF Q38660577-99143ECA-EC3D-4CE9-9BF3-1317AC1E4167 Q38866173-1264ED6E-78CA-42DA-8D6C-F6DF6377C7EF Q39382025-0219B7E7-1C93-4CEF-BE3E-BB0F7CED4D62 Q39780595-4085A15A-2BC7-4240-9288-4EC1ABC3811A Q40280801-0EF43F8C-A726-4E83-B4A6-6FD23DBA5866 Q41067799-ED1BC064-65BF-4094-9906-43C822764516 Q41684063-2228B70A-2227-41B2-8FB7-B5C963170E28 Q42326770-D20FE52D-4FFD-4493-92D1-33BF8BA9B947

P2860

TLR9-targeted biodegradable nanoparticles as immunization vectors protect against West Nile encephalitis.

http://www.wikidata.org/entity/Q37120117

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 26 July 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

TLR9-targeted biodegradable na ...... gainst West Nile encephalitis.

@en

TLR9-targeted biodegradable na ...... gainst West Nile encephalitis.

@nl

type

label

TLR9-targeted biodegradable na ...... gainst West Nile encephalitis.

@en

TLR9-targeted biodegradable na ...... gainst West Nile encephalitis.

@nl

prefLabel

TLR9-targeted biodegradable na ...... gainst West Nile encephalitis.

@en

TLR9-targeted biodegradable na ...... gainst West Nile encephalitis.

@nl

P1433

Q37120117-852AD7D9-E0E3-4745-A7C5-3E1AC7276A21

P1476

Q37120117-76321FA8-23D9-4AA8-8329-6151F8392020

P2093

Q37120117-30B226AD-E543-45D9-947D-7D9131AC7467

Q37120117-4342EFBD-C645-4554-9405-C19420126BE8

Q37120117-47E0EFE2-A65C-4EEA-89D5-170977322B22

Q37120117-4EEC4F12-6F6F-4DDB-B769-7303E50A1C7A

Q37120117-A27FBBB1-EF8B-4A35-B829-FCB1406DB9CE

Q37120117-AEDF5EDB-5F67-41E4-973F-EA6C2BDA8FDC

P2860

Q37120117-000838CD-D149-4B7B-B86C-17179541DED3

Q37120117-0336545A-5A06-41D3-84AF-75D88DA1D860

Q37120117-0541E3F7-CE04-4504-B73C-FB60B8607FF1

Q37120117-07D8E151-9561-43DA-B644-879CEE8BA07E

Q37120117-090C6928-65A6-479C-BE4F-71D2FBB442E8

Q37120117-09B2F55D-E5DB-4A80-94D8-D8C9D58289E7

Q37120117-0B16C8C1-4B90-45D2-B59A-089158598F78

Q37120117-0CA85601-2DD7-46FE-9142-F485CEAB1A8D

Q37120117-1A204B1F-A0F2-4983-8A71-8206823B9A67

Q37120117-1A48045F-DB28-45CF-9789-E87EB29A7686

P304

Q37120117-F9A1C933-64B6-4685-90A1-6C565B635FC4

P31

Q37120117-C37D40D0-8931-4E7E-9FB2-4F352856CBA1

P356

Q37120117-57A58114-25DB-4A2A-ADDF-06A01C7E07BD

P407

Q37120117-9C733403-A8FE-4174-B0E3-E741DCC4BD2B

P433

Q37120117-EDC5D13E-6622-4A2A-AD3B-60A902DA1131

P478

Q37120117-D3E56350-86BF-43FE-87AF-9CE13FE09A4C

P50

Q37120117-78CE4D30-7AFB-431E-B868-8D6FE9FEC895

Q37120117-B93142BD-3BF9-4A0C-881F-82545F55B731

P577

Q37120117-D9D95349-C81F-493B-AD56-1583A16A0ECA

P5875

Q37120117-E9936893-2163-4AC2-B471-D82FC7EDA6DC

P698

Q37120117-0105C072-29DA-40ED-B721-0B8A4A6EB217

P921

Q37120117-052CF7BE-911C-449B-B9AE-53FDBA4B677D

Q37120117-470CC36F-0CF3-4074-A40D-70D16124BD65

Q37120117-68100226-5712-4572-B2C1-85DD2C3DAC0F

Q37120117-8AE9F252-9089-49BC-8F0F-C417EB6BCC3E

Q37120117-96449C45-1222-4EB5-89DA-D6F0ED47B2A1

P932

Q37120117-AFDDFD8E-90EE-4E69-9539-E3FB43A12ED3

P356

JIMMUNOL.1000768

P1433

Journal of Immunology

P1476

TLR9-targeted biodegradable na ...... gainst West Nile encephalitis.

@en

P2093

Michael J Caplan

http://www.w3.org/2001/XMLSchema#string

Nathalie Bonafé

http://www.w3.org/2001/XMLSchema#string

Stacey L Demento

http://www.w3.org/2001/XMLSchema#string

Susan M Kaech

http://www.w3.org/2001/XMLSchema#string

Tarek M Fahmy

http://www.w3.org/2001/XMLSchema#string

Weiguo Cui

http://www.w3.org/2001/XMLSchema#string

P2860

A Toll-like receptor recognizes bacterial DNA

Screening of protective antigens of Japanese encephalitis virus by DNA immunization: a comparative study with conventional viral vaccines

West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays.

West Nile virus/dengue type 4 virus chimeras that are reduced in neurovirulence and peripheral virulence without loss of immunogenicity or protective efficacy

Protective and therapeutic capacity of human single-chain Fv-Fc fusion proteins against West Nile virus

A live, attenuated recombinant West Nile virus vaccine.

Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus

CD4+ T-Cell Responses Are Required for Clearance of West Nile Virus from the Central Nervous System

Two Complex, Adenovirus-Based Vaccines That Together Induce Immune Responses to All Four Dengue Virus Serotypes

Preparation and immunogenic properties of a recombinant West Nile subunit vaccine

P304

2989-2997

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4049/JIMMUNOL.1000768

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

185

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-07-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

45366310

http://www.w3.org/2001/XMLSchema#string

P698

20660705

http://www.w3.org/2001/XMLSchema#string

P921

West Nile virus

Toll-like receptor

P932

3753007

http://www.w3.org/2001/XMLSchema#string